Novo Nordisk AS (NOVO B):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Novo Nordisk AS (NOVO B) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7441
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Novo Nordisk A/S (Novo Nordisk), a subsidiary of Novo A/S discovers, develops and manufactures innovative biological medicines. It focuses at developing drugs for treating diabetes and other serious chronic conditions including hemophilia, growth disorders and obesity. The company’s product portfolio includes new-generation insulins, modern insulins, human insulins, oral antidiabetic agents, diabetes devices and others. Novo Nordisk also offers biopharmaceuticals for treating haemostasis, human growth hormone products, hormone replacement therapy and other serious chronic diseases. With subsidiaries in Europe, North America, Asia, Latin America, Africa, Middle East and Australia, the company markets its products in several countries worldwide. Novo Nordisk is headquartered in Bagsvaerd, Denmark.

Novo Nordisk AS (NOVO B) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Novo Nordisk AS, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Novo Nordisk AS, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Novo Nordisk AS, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Novo Nordisk AS, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Novo Nordisk AS, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Novo Nordisk AS, Medical Equipment, Deal Details 11
Venture Financing 11
Beta Bionics Raises up to USD50 Million in Series B Venture Financing 11
Partnerships 12
Roche Enters into Development Agreement with Novo Nordisk 12
Novo Nordisk Forms Partnership with Dexcom and Glooko 13
Novo Nordisk Enters into Agreement with Glooko 14
Novo Nordisk Enters into Agreement with IBM Watson Health 15
Novo Nordisk Enters into Research Agreement with Massachusetts Institute of Technology 16
BioClinica Enters Into Agreement With NNIT For Clinical Trial Management System 17
Novo Nordisk Enters Into Co-Development Agreement With Oxford University 18
Equity Offering 19
NNIT Prices IPO for USD191 Million 19
Acquisition 21
Novo Nordisk Acquires Ziylo for USD800 Million 21
Novo Nordisk AS – Key Competitors 23
Novo Nordisk AS – Key Employees 24
Novo Nordisk AS – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 30
Strategy And Business Planning 30
Apr 18, 2018: Sempre Health and Novo Nordisk Partner to Improve Medication Costs for Patients With Diabetes 30
Financial Announcements 31
May 02, 2018: Novo Nordisk’s operating profit decreased by 8% in Danish kroner and increased by 6% in local currencies in the first three months of 2018 31
Feb 01, 2018: Novo Nordisk increased reported operating profit by 1% in 2017 to DKK 49 billion (5% growth in local currencies) 32
Nov 01, 2017: Novo Nordisk increased reported operating profit by 5% in the first nine months of 2017 33
Aug 09, 2017: Novo Nordisk increased reported operating profit by 8% in the first six months of 2017 34
May 03, 2017: Novo Nordisk increased reported operating profit by 10% in the first three months of 2017 35
Feb 02, 2017: Novo Nordisk increased adjusted operating profit by 6% in local currencies in 2016 36
Corporate Communications 37
Oct 15, 2018: Novo Nordisk appoints Ludovic Helfgott executive vice president Biopharm 37
Sep 20, 2018: Novo Nordisk to lay off 400 employees in Denmark and China 38
Aug 15, 2017: Changes in Novo Nordisk Executive Management 39
May 16, 2017: Change in composition of the Board of Directors of Novo Nordisk 40
May 16, 2017: Change in composition of the Board of Directors of Novo Nordisk 41
Mar 01, 2017: Change in Novo Nordisk Executive Management 42
Other Significant Developments 43
Aug 08, 2018: Novo Nordisk’s operating profit decreased by 8% in danish kroner and increased by 4% in local currencies in the first six months of 2018 43
Sep 26, 2017: Novo Nordisk Teams Up with HITLAB to Challenge Innovators to Develop Voice-Activated Technology for Diabetes Care with $75,000 in Prizes 44
Jul 12, 2017: Novo Nordisk and Glooko advance their digital health collaboration with launch of unique integrated app for improved diabetes management 45
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
Novo Nordisk AS, Medical Equipment, Key Facts, 2017 2
Novo Nordisk AS, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Novo Nordisk AS, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Novo Nordisk AS, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Novo Nordisk AS, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Novo Nordisk AS, Deals By Market, 2012 to YTD 2018 9
Novo Nordisk AS, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Beta Bionics Raises up to USD50 Million in Series B Venture Financing 11
Roche Enters into Development Agreement with Novo Nordisk 12
Novo Nordisk Forms Partnership with Dexcom and Glooko 13
Novo Nordisk Enters into Agreement with Glooko 14
Novo Nordisk Enters into Agreement with IBM Watson Health 15
Novo Nordisk Enters into Research Agreement with Massachusetts Institute of Technology 16
BioClinica Enters Into Agreement With NNIT For Clinical Trial Management System 17
Novo Nordisk Enters Into Co-Development Agreement With Oxford University 18
NNIT Prices IPO for USD191 Million 19
Novo Nordisk Acquires Ziylo for USD800 Million 21
Novo Nordisk AS, Key Competitors 23
Novo Nordisk AS, Key Employees 24
Novo Nordisk AS, Subsidiaries 25

List of Figures
Novo Nordisk AS, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Novo Nordisk AS, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Novo Nordisk AS, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Novo Nordisk AS, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Novo Nordisk AS, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Novo Nordisk AS, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Novo Nordisk AS, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Novo Nordisk AS, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Novo Nordisk AS (NOVO B):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kindred Healthcare, Inc.:戦略・SWOT・企業財務分析
    Kindred Healthcare, Inc. - Strategy, SWOT and Corporate Finance Report Summary Kindred Healthcare, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • California Cryobank:製薬・医療:M&Aディール及び事業提携情報
    Summary California Cryobank (CCB) is a healthcare service provider that offers reproductive, stem cell and donor selection services. The center offers services such as donor semen, pricing, donor information subscriptions, graduate donors, donor information, consultation services, genetic services, …
  • Bespak Europe Ltd:企業の製品パイプライン分析2018
    Summary Bespak Europe Ltd (Bespak), a subsidiary of Consort Medical plc is a medical device company that provides inhalation systems. The company provides products such as inhalation devices, injectables, medical check valves and nasal products. Its inhalation devices comprise dose counting actuator …
  • Instrumentation Laboratory Company-医療機器分野:企業M&A・提携分析
    Summary Instrumentation Laboratory Company (IL), a subsidiary of Werfen Life Group, is a medical device company with focus on in vitro diagnostics (IVD) devices. The company develops, manufactures, and distributes IVD instruments, related reagents and controls for hospitals and clinical laboratories …
  • AGL Energy Ltd (AGL):石油・ガス:M&Aディール及び事業提携情報
    Summary AGL Energy Limited (AGL) is an integrated energy company that owns, operates and develops energy assets and provides natural gas, electricity, solar photovoltaic solutions and related products and services. The company’s power generation portfolio includes coal, gas, hydro, wind, solar, land …
  • Interface Biologics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Interface Biologics Inc (IBI) is a medical device company that develops transformative biomedical polymer technologies. The company offers anti-thrombogenic and combination drug delivery devices. Its anti-thrombogenic additives reduce thrombosis in blood contacting medical devices and polyme …
  • Trillion Energy International Inc (PKPL):企業の財務・戦略的SWOT分析
    Summary Trillion Energy International Inc (Trillion Energy) formerly Park Place Energy Inc, is an oil and gas company that offers exploration and development of oil and natural gas. The company offers various oil and gas services such as drilling, exploration, development, production, distribution a …
  • Macquarie Group Ltd:企業のM&A・事業提携・投資動向
    Macquarie Group Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Macquarie Group Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Tecan Group Ltd (TECN):製薬・医療:M&Aディール及び事業提携情報
    Summary Tecan Group Ltd (Tecan) is a provider of automated laboratory instruments and solutions for use in basic and translational research, clinical diagnostics, and drug discovery. The company develops, manufactures, and markets automated workflow solutions for laboratories and instrumentation sup …
  • Oriflame Holding AG:企業の戦略・SWOT・財務分析
    Oriflame Holding AG - Strategy, SWOT and Corporate Finance Report Summary Oriflame Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • PetroMaroc Corporation Plc (PMA):企業の財務・戦略的SWOT分析
    Summary PetroMaroc Corporation Plc (Petromaroc), formerly Longreach Oil and Gas Ltd, is an oil and gas exploration and development company that evaluates, acquires, explores and develops oil and gas properties in Morocco. The company holds interests in the Sidi Moktar licence area which includes geo …
  • Crohn’s & Colitis Foundation Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Crohn's & Colitis Foundation Inc (CCF) is a non-profit organization that provides treatments for crohn's disease and ulcerative colitis. The organization funds studies at medical institutions, nurture investigators, and finance underdeveloped areas of research. It provides clinical research …
  • BaxterStorey Ltd:企業の戦略・SWOT・財務分析
    BaxterStorey Ltd - Strategy, SWOT and Corporate Finance Report Summary BaxterStorey Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • MAB Discovery GmbH-製薬・医療分野:企業M&A・提携分析
    Summary MAB Discovery GmbH (MAB Discovery) is a drug discovery and development company that offers novel antibody therapeutics. The company produces monoclonal antibodies derived from rabbits and rats. It relies on natural immune response and state of the art B cell cloning techniques for the produc …
  • Akebia Therapeutics Inc (AKBA):企業の財務・戦略的SWOT分析
    Summary Akebia Therapeutics Inc (Akebia Therapeutics) is a biopharmaceutical company focused on the development and commercialization of novel therapeutics based on hypoxia inducible factor for patients with kidney disease and other metabolic disorders. Its lead product candidate vadadustat is a HIF …
  • 01 Communique (ONE):企業の財務・戦略的SWOT分析
    Summary 01 Communique (Communique) is a technology company that develops and delivers integrated communication software and services. The company's products include I'm InTouch meeting, I'm InTouch, I'm OnCall and Communicate!. Its I'm InTouch provides a secure and easy to use PC remote access softw …
  • Exxon Mobil Corp (XOM):石油・ガス:M&Aディール及び事業提携情報
    Summary Exxon Mobil Corp (ExxonMobil) is an integrated oil and gas company that explores for and produces crude oil and natural gas; manufactures petroleum products; transports and sells crude oil and petroleum products; and markets natural gas and natural gas liquids. It is a major manufacturer and …
  • British Arab Commercial Bank plc:企業の戦略的SWOT分析
    British Arab Commercial Bank plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Bone Solutions Inc:医療機器:M&Aディール及び事業提携情報
    Summary Bone Solutions Inc (BSI) is a medical device company that provides orthobiologics technology solutions. The company also develops magnesium oxide based technologies for multitude of orthopedic applications. It provides osteocrete bone graft substitute that offers adhere ligaments and tendons …
  • Kurabo Industries Ltd (3106):企業の財務・戦略的SWOT分析
    Kurabo Industries Ltd (3106) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆